{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:53:18Z","timestamp":1761918798999,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ajog.2006.03.011","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T08:50:35Z","timestamp":1146646235000},"page":"1676-1681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin"],"prefix":"10.1016","volume":"194","author":[{"given":"Dena","family":"Towner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"El Kady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2006.03.011_bib1","first-page":"17","article-title":"Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels","volume":"74","author":"Robinson","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-9378(91)90289-4","article-title":"Risks associated with an elevated maternal serum alpha-fetoprotein level","volume":"165","author":"Crandall","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib3","first-page":"556","article-title":"Data from an alpha-fetoprotein pilot screening program in Maine","volume":"62","author":"Haddow","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0002-9378(12)80033-0","article-title":"Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes","volume":"167","author":"Williams","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/0002-9378(93)90701-J","article-title":"An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome","volume":"168","author":"Lieppman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ajmg.1320440420","article-title":"Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome","volume":"44","author":"Gravett","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2006.03.011_bib7","first-page":"83","article-title":"The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications","volume":"80","author":"Gonen","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0029-7844(95)00390-8","article-title":"Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein","volume":"87","author":"Benn","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib10","first-page":"341","article-title":"Fetal growth in patients with elevated maternal serum hCG levels","volume":"81","author":"Tanaka","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib11","unstructured":"National Vital Statistics System Birth Data 2002. Available at: http:\/\/www.cdc.gov\/nchs\/births.htm. Accessed May 2005."},{"key":"10.1016\/j.ajog.2006.03.011_bib12","first-page":"929","article-title":"Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening","volume":"94","author":"van Rijn","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib13","first-page":"138","article-title":"Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss","volume":"83","author":"Maher","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9378(89)90371-2","article-title":"Glycemic control in gestational diabetes mellitus\u2013how tight is tight enough: small for gestational age versus large for gestational age?","volume":"161","author":"Langer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.03.011_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/pd.1970151109","article-title":"Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery","volume":"15","author":"Morssink","year":"1995","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2006.03.011_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-0528.1996.tb09873.x","article-title":"The relation between serum markers in the second trimester and placental pathology: a study on extremely small for gestational age fetuses","volume":"103","author":"Morssink","year":"1996","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2006.03.011_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4615-4711-2_20","article-title":"Oxygen and placental vascular development","volume":"474","author":"Kingdom","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajog.2006.03.011_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0143-4004(98)90002-9","article-title":"Fetal growth retardation and second trimester maternal serum human chorionic gonadotrophin levels","volume":"19","author":"Luckas","year":"1998","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2006.03.011_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6","article-title":"Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2006.03.011_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ajcp\/111.2.209","article-title":"Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels","volume":"111","author":"Liu","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2006.03.011_bib21","first-page":"327","article-title":"Relationship of fetal and placental weight in human beings: fetal\/placental weight ratios at various gestational ages and birth weight distributions","volume":"21","author":"Molteni","year":"1978","journal-title":"J Reprod Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806003346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806003346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:16:06Z","timestamp":1757585766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937806003346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0002937806003346"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2006.03.011","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2006.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}